News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Daily News Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos August 13, 2015
Presentation Antisense Inhibition of Apolipoprotein C-III in Patients With Hypertriglyceridemia Presenter: D. Gaudet August 12, 2015
News Industry News Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid Parameters for Individual Hyperlipidemic Patients Switched to Vascepa(R) June 11, 2014